학술논문

Health-Related Quality of Life with Guselkumab Induction and Maintenance Therapy as Measured by PROMIS-29: Results Through Week 48 of Phase 2 GALAXI 1 Study
Document Type
Journal
Source
AMERICAN JOURNAL OF GASTROENTEROLOGY; OCT 2022, 117 10, pS569-pS570, 2p. Supplement: S
Subject
Language
English
ISSN
15720241